BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23801141)

  • 1. A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy.
    Awano N; Inomata M; Sonoda Y; Kondoh K; Ono R; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
    J Clin Exp Hematop; 2013; 53(1):101-5. PubMed ID: 23801141
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
    Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
    J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
    Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
    J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
    Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
    J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAFRO Syndrome.
    Igawa T; Sato Y
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Castleman disease].
    Meignin V; Calvani J; Oksenhendler E
    Ann Pathol; 2023 Jan; 43(1):13-24. PubMed ID: 36192235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
    Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAFRO Syndrome with an Anterior Mediastinal Mass and Lethal Autoantibody-Mediated Thrombocytopenia: An Autopsy Case Report.
    Morita K; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ashizawa K; Yamamoto Y; Oshiro H; Kanda Y
    Acta Haematol; 2019; 141(3):158-163. PubMed ID: 30799408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenalitis and anasarca in idiopathic multicentric Castleman's disease.
    Chen LYC; Skinnider BF; Wilson D; Fajgenbaum DC
    Lancet; 2021 May; 397(10286):1749. PubMed ID: 33965090
    [No Abstract]   [Full Text] [Related]  

  • 10. Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.
    Awano N; Inomata M; Kondoh K; Satake K; Kamiya H; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
    Intern Med; 2012; 51(21):3061-6. PubMed ID: 23124151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases.
    Takai K; Nikkuni K; Momoi A; Nagai K; Igarashi N; Saeki T
    J Clin Exp Hematop; 2013; 53(1):63-8. PubMed ID: 23801136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafro syndrome: Critical review for clinicians and pathologists.
    Paydas S
    Crit Rev Oncol Hematol; 2018 Aug; 128():88-95. PubMed ID: 29958635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transitional variant of Castleman's disease presenting as a chylous pleural effusion.
    Ten Hoor T; Hewan-Lowe K; Miller JI; Moss M
    Chest; 1999 Jan; 115(1):285-8. PubMed ID: 9925102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
    Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
    J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
    Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
    Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.
    Coutier F; Meaux Ruault N; Crepin T; Bouiller K; Gil H; Humbert S; Bedgedjian I; Magy-Bertrand N
    Ann Hematol; 2018 Mar; 97(3):401-407. PubMed ID: 28956126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute.
    Kawabata H; Kadowaki N; Nishikori M; Kitawaki T; Kondo T; Ishikawa T; Yoshifuji H; Yamakawa N; Imura Y; Mimori T; Matsumura Y; Miyachi Y; Matsubara T; Yanagita M; Haga H; Takaori-Kondo A
    J Clin Exp Hematop; 2013; 53(1):69-77. PubMed ID: 23801137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Castleman's disease presenting as a pediatric surgical problem.
    Shroff VJ; Gilchrist BF; DeLuca FG; McCombs HL; Wesselhoeft CW
    J Pediatr Surg; 1995 May; 30(5):745-7. PubMed ID: 7623245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.